Tag:
Nautilus Neurosciences
Latest Headlines
Latest Headlines
Tribute Pharma gains Canadian nod for migraine powder
Canada's Tribute Pharmaceuticals got the green light from Health Canada to market Cambia, a migraine-relief drug that uses Swiss drug delivery company Applied Pharma Research's patented water-soluble powder.
Nautilus gets funding to support migraine drug launch
New Jersey's Nautilus Neurosciences has received an undisclosed investment from Galen Partners to support commercialization of its migraine treatment Cambia, which is set to launch in the first half
